Stimulation of fibrotic processes by the infrapatellar fat pad in cultured synoviocytes from patients with osteoarthritis: A possible role for prostaglandin F2α

Arthritis and Rheumatism

Volumn 65, Issue 8, 2013, Pages 2070-2080

  Bastiaansen Jenniskens, Yvonne M ^a   Wei, Wu ^a   Feijt, Carola ^a   Waarsing, Jan H ^a   Verhaar, Jan A N ^a   Zuurmond, Anne Marie ^b   Hanemaaijer, Roeland ^b   Stoop, Reinout ^b   Van Osch, Gerjo J V M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 1; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; GENE; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIOCYTE;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, CONDITIONED; DINOPROST; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATELLA; PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; SYNOVIAL MEMBRANE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84881342977     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37996     Document Type: Article

References (47)

1. Yusuf E, Bijsterbosch J, Slagboom PE, Rosendaal FR, Huizinga TW, Kloppenburg M,. Body mass index and alignment and their interaction as risk factors for progression of knees with radiographic signs of osteoarthritis. Osteoarthritis Cartilage 2011; 19: 1117-22.
2. Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007; 66: 158-62.
3. Revell PA, Mayston V, Lalor P, Mapp P,. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988; 47: 300-7.
4. Hutton CW, Hinton C, Dieppe PA,. Intra-articular variation of synovial changes in knee arthritis: biopsy study comparing changes in patellofemoral synovium and the medial tibiofemoral synovium. Br J Rheumatol 1987; 26: 5-8.
5. Loeuille D, Chary-Valckenaere I, Champigneulle J, Rat AC, Toussaint F, Pinzano-Watrin A, et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum 2005; 52: 3492-501.
6. Gharaee-Kermani M, Phan SH,. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des 2001; 7: 1083-103.
7. Gabbiani G,. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500-3.
8. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G,. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-11.
9. Ronnov-Jessen L, Petersen OW,. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts: implications for myofibroblast generation in breast neoplasia. Lab Invest 1993; 68: 696-707.
10. Van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, et al. Identification of Plod2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003; 278: 40967-72.
11. Van der Slot AJ, Zuurmond AM, van den Bogaerdt AJ, Ulrich MM, Middelkoop E, Boers W, et al. Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol 2004; 23: 251-7.
12. Remst DF, Blaney Davidson EN, Vitters EL, Blom AB, Stoop R, Snabel JM, et al. Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression. Osteoarthritis Cartilage 2013; 21: 157-64.
13. Van der Slot AJ, van Dura EA, de Wit EC, De Groot J, Huizinga TW, Bank RA, et al. Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta 2005; 1741: 95-102.
14. 2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-β. Nat Med 2009; 15: 1426-30.
15. Olman MA,. Beyond TGF-β: a prostaglandin promotes fibrosis. Nat Med 2009; 15: 1360-1.
16. Chen WP, Bao JP, Feng J, Hu PF, Shi ZL, Wu LD,. Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis. Clin Chem Lab Med 2010; 48: 1141-5.
17. Clockaerts S, Bastiaansen-Jenniskens YM, Feijt C, De Clerck L, Verhaar JA, Zuurmond AM, et al. Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1β and inhibited by peroxisome proliferator activated receptor α agonist. Ann Rheum Dis 2012; 71: 1012-8.
18. Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, Yusuf E, Kwekkeboom JC, El-Bannoudi H, et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis 2011; 70: 851-7.
19. Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S, et al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis: contribution of joint tissues to their articular production. Osteoarthritis Cartilage 2006; 14: 690-5.
20. Ushiyama T, Chano T, Inoue K, Matsusue Y,. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann Rheum Dis 2003; 62: 108-12.
21. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, van Osch GJ, Van Offel JF, Verhaar JA, et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010; 18: 876-82.
22. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW,. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-82.
23. Fain JN,. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-77.
24. Fain JN, Tichansky DS, Madan AK,. Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes. Metabolism 2006; 55: 1113-21.
25. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M,. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003; 300: 674-8.
26. Fain JN, Madan AK,. Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int J Obes (Lond) 2005; 29: 1299-307.
27. Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS,. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring) 2010; 18: 890-6.
28. Bastiaansen-Jenniskens YM, de Bart AC, Koevoet W, Jansen KM, Verhaar JA, van Osch GJ, et al. Elevated levels of cartilage oligomeric matrix protein during in vitro cartilage matrix generation decrease collagen fibril diameter. Cartilage 2010; 1: 200-10.
29. Balvers MG, Verhoeckx KC, Meijerink J, Bijlsma S, Rubingh CM, Wortelboer HM, et al. Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum and adipose tissue in C57BL/6 mice fed a fish-oil diet. Int Immunopharmacol 2012; 13: 204-14.
30. Pelletier JP, Martel-Pelletier J, Abramson SB,. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [review]. Arthritis Rheum 2001; 44: 1237-47.
31. Kershaw EE, Flier JS,. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56.
32. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW,. Integrative physiology of human adipose tissue [review]. Int J Obes Relat Metab Disord 2003; 27: 875-88.
33. Galic S, Oakhill JS, Steinberg GR,. Adipose tissue as an endocrine organ. Mol Cell Endocrinology 2010; 316: 129-39.
34. Distel E, Cadoudal T, Durant S, Poignard A, Chevalier X, Benelli C,. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum 2009; 60: 3374-7.
35. Shi Q, Liu X, Bai Y, Cui C, Li J, Li Y, et al. In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS One 2011; 6: e28134.
36. 2α enhances phenotypic transformation of normal rat kidney fibroblasts. Am J Physiol Cell Physiol 2005; 289: C130-7.
37. Olson DM, Tanswell AK,. Production of prostaglandins by fetal rat lung type II pneumonocytes and fibroblasts. Biochim Biophys Acta 1989; 1003: 327-30.
38. Van der Slot-Verhoeven AJ, van Dura EA, Attema J, Blauw B, Degroot J, Huizinga TW, et al. The type of collagen cross-link determines the reversibility of experimental skin fibrosis. Biochim Biophys Acta 2005; 1740: 60-7.
39. Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, Zuurmond AM, Stojanovic-Susulic V, Bridts C, et al. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage. Ann Rheum Dis 2012; 71: 288-94.
40. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH,. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation. J Leuk Biol 2006; 79: 285-93.
41. Norwitz ER, Lopez Bernal A, Starkey PM,. Tumor necrosis factor-α selectively stimulates prostaglandin F2α production by macrophages in human term decidua. Am J Obstet Gynecol 1992; 167: 815-20.
42. O'Sullivan MG, Chilton FH, Huggins EM Jr, McCall CE,. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem 1992; 267: 14547-50.
43. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L,. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 2010; 6: 71-82.
44. Samuelsson B,. Prostaglandins and thromboxanes. Recent Prog Horm Res 1978; 34: 239-58.
45. De Grauw JC, van de Lest CH, van Weeren PR,. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 2009; 11: R35.
46. Mastbergen SC, Marijnissen AC, Vianen ME, Zoer B, van Roermund PM, Bijlsma JW, et al. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford) 2006; 45: 405-13.
47. De Grauw JC, van de Lest CH, van Weeren PR,. A targeted lipidomics approach to the study of eicosanoid release in synovial joints. Arthritis Res Ther 2011; 13: R123.